7U

Braster SAFRA Braster Stock Report

Last reporting period 30 Sep, 2023

Updated —

Last price

Market cap $B

0.004

Micro

Exchange

XFRA - Deutsche Boerse AG

7UD.F Stock Analysis

7U

Uncovered

Braster SA is uncovered by Eyestock quantitative analysis.

Market cap $B

0.004

Dividend yield

Shares outstanding

28.393 B

Braster SA engages in the development and manufacturing of medical devices for self-examination. The firm provides research and development on breast cancer. The company applies liquid crystals and liquid crystal emulsion formula that is used to produce liquid crystal matrix based on LCD technology, continuous film CLCF (Continuous Liquid Crystal Film) in the diagnosis of breast cancer. Its main product is Braster Tester, which is a device that uses thermographic liquid crystal matrices for diagnosing breast cancer; the device is made up of three film matrices covered with a liquid crystal mixture that allows thermal imaging. The firm cooperates with the Jagiellonian University, with the participation of the clinical trial conducted by Thermacrac, among others.

View Section: Eyestock Rating